// App-Quantinova.ai

3361 : Targeting tumor/cancer stem cell marker DCLK1 for the treatment of hepatocellular carcinoma and erlotinib-resistant lung adenocarcinoma using Z-3,5,4-Trimethoxystilbene (Z-TMS)

Researchers

Presenter

  • Naushad Ali

Principal Investigators

  • Charles B. Nguyen

  • Sanam Husain

  • Parthasarathy Chandrakesan

  • Randal May

  • Sripathi Sureban

  • Nathaniel Weygant

  • Dongfeng Qu

  • Danny N. Dhanasekaran

  • Michael Bronze

  • Courtney Houchen

Medical Centers

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • Resveratrol

  • Erlotinib hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved